13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SC Filed 2021-03-22 Event — SEC 0000947871-21-000353 →

ORBIMED ADVISORS LLC → Oric Pharmaceuticals, Inc. ORIC

Stake: — Shares: —
Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 25/100 · Filer 90d Win Rate: 25% · Hist. 90d Edge: -5.4%
  • Filer track record (12 filings): 25% 90d win rate, +0.0% 90d edge
  • Held by 2 tracked 13F institutional managers
  • Elevated short days-to-cover (10.5 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
34 transactions
11 buys · 7 sales · 16 awards/exercises
Issuer Cluster
4 13D/G filings on this issuer
3 other filings besides this one
Filer Track Record
145 filings by this filer
144 other filings in the data moat
Short Interest · settle 2026-10-15
DTC 10.50
15,422,384 shares short · -5.5% vs prior

Institutional Consensus · 2026-06-30

Held by elite portfolio managers
2 holders · $79.43M
Point72 Asset MgmtViking Global

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-09-28 Piscitelli Dominic officer Option exercise 13,400 $4.36 $58K
2026-09-28 Piscitelli Dominic officer Sale 13,400 $13.53 $181K
2026-02-24 Piscitelli Dominic officer Option exercise 52,000 $4.36 $227K
2026-02-24 Piscitelli Dominic officer Sale 52,000 $13.51 $703K
2026-01-16 Heyman Richard A. director Sale 3,500 $12.00 $42K
2026-01-16 Heyman Richard A. director Sale 3,200 $12.00 $38K
2026-01-02 You Angie director Award 40,000 $8.17 $327K
2026-01-02 Kunkel Lori Anne director Award 40,000 $8.17 $327K
2026-01-02 Hoerter Steven L. director Award 40,000 $8.17 $327K
2026-01-02 Heyman Richard A. director Award 40,000 $8.17 $327K
2026-01-02 Dier Mardi director Award 40,000 $8.17 $327K
2026-01-02 Piscitelli Dominic officer Award 206,500 $8.17 $1.69M
2026-01-02 Multani Pratik S officer Award 214,000 $8.17 $1.75M
2026-01-02 Chacko Jacob director, officer Award 675,000 $8.17 $5.51M
2026-01-02 Multani Pratik S officer Award 35,500 — —
2026-01-02 Chacko Jacob director, officer Award 112,500 — —
2026-01-02 Piscitelli Dominic officer Award 34,500 — —
2025-12-16 Multani Pratik S officer Sale 10,720 $9.06 $97K
2025-12-16 Chacko Jacob director, officer Sale 33,374 $9.06 $302K
2025-12-16 Piscitelli Dominic officer Sale 10,720 $9.06 $97K
2025-12-15 Multani Pratik S officer Option exercise 29,333 — —
2025-12-15 Piscitelli Dominic officer Option exercise 29,333 — —
2025-12-15 Chacko Jacob director, officer Option exercise 83,666 — —
2025-12-15 Multani Pratik S officer Option exercise 8,000 — —
2025-12-15 Multani Pratik S officer Option exercise 10,000 — —
Showing 25 of 34

Other 13D/G Filings on Oric Pharmaceuticals, Inc.

FiledFormFilerStakeShares
2022-12-27 SC ORBIMED ADVISORS LLC — — view →
2021-08-12 SC ORBIMED ADVISORS LLC — — view →
2020-11-18 SC ORBIMED ADVISORS LLC — — view →

Other Filings by ORBIMED ADVISORS LLC

FiledFormIssuerStakeShares
2026-10-08 SCHEDULE 13D/A ArriVent BioPharma, Inc. 5.80% 2,875,962 view →
2026-10-02 SCHEDULE 13D ADARx Pharmaceuticals, Inc. 14.00% 14,913,764 view →
2026-09-25 SCHEDULE 13D Electra Therapeutics, Inc. 11.00% 6,885,170 view →
2026-09-10 SCHEDULE 13D/A Braveheart Bio, Inc. 13.50% 12,175,159 view →
2026-08-18 SCHEDULE 13D BlossomHill Therapeutics, Inc. 8.90% 2,714,279 view →
2026-08-18 SCHEDULE 13D Braveheart Bio, Inc. 17.20% 12,175,159 view →
2026-08-10 SCHEDULE 13D/A MBX Biosciences, Inc. — 3,074,853 view →
2026-08-05 SCHEDULE 13D Yarrow Bioscience, Inc. 9.97% 266,306 view →
2026-07-29 SCHEDULE 13D Scribe Therapeutics, Inc. 7.20% 1,348,825 view →
2026-07-20 SCHEDULE 13D/A Q32 Bio Inc. — 4,127,987 view →
2026-06-24 SCHEDULE 13D/A Enliven Therapeutics, Inc. ELVN — 6,774,507 view →
2026-06-17 SCHEDULE 13D/A Enliven Therapeutics, Inc. ELVN 10.93% 7,634,630 view →
2026-06-15 SCHEDULE 13D/A Shattuck Labs, Inc. STTK — 9,021,127 view →
2026-06-01 SCHEDULE 13D/A Q32 Bio Inc. QTTB — 4,127,987 view →
2026-04-10 SCHEDULE 13D/A Adicet Bio, Inc. ACET 8.80% 844,787 view →
2026-01-27 SCHEDULE Corvus Pharmaceuticals, Inc. CRVS 10.30% 8,609,091 view →
2025-10-10 SCHEDULE Adicet Bio, Inc. ACET 9.60% 14,772,598 view →
2025-09-30 SCHEDULE MBX Biosciences, Inc. MBX 9.00% 4,002,887 view →
2025-07-21 SCHEDULE Passage BIO, Inc. PASG 7.82% 243,878 view →
2025-05-14 SCHEDULE Corvus Pharmaceuticals, Inc. CRVS 12.20% 9,785,423 view →
Showing 20 of 144

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →